Skip to main content
. 2020 Dec 11;12:594324. doi: 10.3389/fnagi.2020.594324

Figure 3.

Figure 3

The levels of Aβ1-42 in CSF from PD-OD and PD-NOD groups. PD-OD, Parkinson disease with olfactory dysfunction; PD-NOD, Parkinson disease with no olfactory dysfunction.